Literature DB >> 19945796

Target genes suitable for silencing approaches and protein product interference in ovarian epithelial cancer.

Anastasia Malek1, Reinhold Schäfer, Oleg Tchernitsa.   

Abstract

Gene expression profiling studies and conventional approaches for the identification of genes involved in the initiation and progression of ovarian cancer have identified a plethora of potential therapeutic targets. This review summarizes the targets that show promise for specific interference in cancer cells, groups them according to their subcellular localization and involved biological processes and discusses their impact on experimental, pre-clinical and clinical therapy. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19945796     DOI: 10.1016/j.ctrv.2009.10.005

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  1 in total

1.  STAMP alters the growth of transformed and ovarian cancer cells.

Authors:  Yuanzheng He; John A Blackford; Elise C Kohn; S Stoney Simons
Journal:  BMC Cancer       Date:  2010-04-07       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.